Join to View Full Profile
1275 York AvenueNew York, NY 10065
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kojo Elenitoba-Johnson, MD is a board certified pathologist in New York, New York. He is currently licensed to practice medicine in New York and Pennsylvania. He is affiliated with Memorial Sloan Kettering Cancer Center and is a Professor at University of Michigan Medical School.
Education & Training
Rhode Island Hospital/Brown University HealthResidency, Pathology-Anatomic and Clinical, 1991 - 1995
University of Lagos College of MedicineClass of 1988
Certifications & Licensure
NY State Medical License 2022 - 2025
PA State Medical License 2015 - 2022
American Board of Pathology Anatomic Pathology & Clinical Pathology- American Board of Pathology Hematology
- American Board of Pathology Molecular Genetic Pathology
Publications & Presentations
PubMed
- The FBXO45-GEF-H1 Axis Controls Germinal Center Formation and B-cell Lymphomagenesis.Anagh A Sahasrabuddhe, Xiaofei Chen, Kaiyu Ma, Rui Wu, Huan-Chang Liang
Cancer Discovery. 2025-04-02 - HLA-I aberrations in cutaneous T-cell lymphoma.Ting Zhou, Kojo S J Elenitoba-Johnson
Blood. 2025-01-16 - 1 citationsHigh-resolution melting assay for rapid, simultaneous detection of,andvariants.Christopher M Sande, Guang Yang, Ayman Mohamed, Ben L Legendre, Danielle Pion
Journal of Clinical Pathology. 2024-08-16
Press Mentions
Association for Molecular Pathology Announces 2018 Award RecipientsAugust 22nd, 2018
This Last-Resort Test Saved 2 Women from Cancer—and It Could Save You, TooAugust 29th, 2017
New Study Discovers "Killer Peptide" That Helps Eliminate Resistant Cancer CellsAugust 19th, 2017
Grant Support
- Genomic biomarkers of splenic lymphomaSLOAN-KETTERING INST CAN RESEARCH2022–2025
- Epiproteomics of Sezary SyndromeSLOAN-KETTERING INST CAN RESEARCH2020–2025
